Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. (REGN)

$320.48 USD

9.65 (3.10%)

Updated Jun 20 4:00pm

Add REGN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

REGN Daily Price Range
REGN 52-Week Price Range

REGN News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All REGN News

Regeneron Pharmaceuticals, Inc. (REGN) Company Bio

Regeneron Pharmaceuticals is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, and atopic dermatitis. The company was founded in 1988 and is based in Tarrytown, New York.

REGN Stock Chart More Charts

REGN Price/Volume Stats

Current price $320.48
Prev. close $310.83
Day low $315.25
Day high $327.83
50-day MA $325.10
200-day MA $373.84
52-week high $442.00
52-week low $295.27
Volume 1,617,075
Avg. volume 788,957
Dividend yield N/A
Market Cap 35.02B

REGN Social Stream

Loading social stream, please wait...

View Full REGN Social Stream

REGN Returns

1-mo 3.40%
3-mo -18.20%
6-mo -7.00%
1-year -4.88%
3-year -9.12%
5-year 12.35%
YTD -14.20%
2018 -0.65%
2017 2.42%
2016 -32.38%
2015 32.33%
2014 49.05%
Page generated in 0.4058 seconds.